DAC
ABMD

Dividend Assets Capital’s Abiomed Inc ABMD Stock Holding History

Dividend Assets Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-405
Closed -$99K – 560
2022
Q3 		$99K Hold
405
– – 0.02% 206
2022
Q2 		$100K Buy
405
+50
+14% +$13.5K 0.02% 218
2022
Q1 		$118K Buy
355
+100
+39% +$30.8K 0.02% 211
2021
Q4 		$92K Buy
255
+105
+70% +$35.5K 0.02% 235
2021
Q3 		$49K Sell
150
-150
-50% -$50.8K 0.01% 298
2021
Q2 		$94K Hold
300
– – 0.02% 235
2021
Q1 		$96K Buy
300
+100
+50% +$32K 0.02% 236
2020
Q4 		$65K Buy
+200
New +$55.3K 0.01% 254

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dividend Assets Capital's ABMD Position: Q4 2022 in Review

Dividend Assets Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 405 shares — an estimated $99K sold.

Dividend Assets Capital first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $118K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Dividend Assets Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Dividend Assets Capital sold 405 Abiomed Inc shares in Q4 2022, an estimated $99K.
  • Dividend Assets Capital first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Dividend Assets Capital's Abiomed Inc position peaked at $118K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Dividend Assets Capital's 13F filing for Q4 2022, filed 10 Feb 2023.